Skip to main content
SpringerLink
Log in
Book cover

Critical Care for Potential Liver Transplant Candidates pp 119–146Cite as

Management of Thrombosis in the Liver Transplant Candidate

  • Chapter
  • First Online:

  • 831 Accesses

Abstract

Liver cirrhosis is associated with thrombotic complications. Both local and systemic factors can result in the development of this site-specific thrombosis. The portal vein is the most common site for thrombus formation, with 1-year incidence ranging from 7.4 to 11%. The association between liver cirrhosis and peripheral venous thromboembolism has been described in 0.8–7% of hospitalized cirrhotic patients. Another thrombotic complication that can lead to liver failure and the need for a liver transplantation is a thrombotic obstruction of hepatic venous outflow defined as Budd-Chiari syndrome (BCS). BCS occurs in 0.2 per million per year with a prevalence ranging from 1/1.000.000 of the general population in the East up to 1/100.000 in Nepal. Treatment of thrombotic complications in cirrhotic patients is based on anticoagulation, which has been demonstrated to be both safe and effective. The early initiation of anticoagulant therapy after the development of portal thrombosis is the most important factor for predicting a response to therapy, with a recanalization rate of up to 75% for PVT in cirrhosis and 30% in patients with BCS. For patients who do not respond adequately to medical therapy, TIPS can be attempted. In BCS angioplasty/stenting/thrombolysis can be considered as the second-line treatment, and TIPS is the treatment of choice when thrombosis affects multiple hepatic veins or in cases of severe ascites. Finally, liver transplantation remains the treatment of choice in cirrhotics who have PVT, in cases of hyperacute presentation of BCS, and in cases in which TIPS has failed.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44:1039.

    Article  CAS  PubMed  Google Scholar 

  2. Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT, et al. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol. 2010;53:362.

    Article  PubMed  Google Scholar 

  3. Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandroni M, Mannucci PM, et al. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Hepatology. 1996;23:1377.

    Article  CAS  PubMed  Google Scholar 

  4. Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA. Factor VIII expression in liver disease. Thromb Haemost. 2004;91:267.

    Article  CAS  PubMed  Google Scholar 

  5. Kelly DA, Summerfield JA. Hemostasis in liver disease. Semin Liver Dis. 1987;7:182.

    Article  CAS  PubMed  Google Scholar 

  6. Kerr R. New insights into haemostasis in liver failure. Blood Coagul Fibrinolysis. 2003;14(Suppl 1):S43.

    Article  CAS  PubMed  Google Scholar 

  7. Maisonneuve P, Sultan Y. Modification of factor VIII complex properties in patients with liver disease. J Clin Pathol. 1977;30:221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Blanchard RA, Furie BC, Jorgensen M, Kruger SF, Furie B. Acquired vitamin K-dependent carboxylation deficiency in liver disease. N Engl J Med. 1981;305:242.

    Article  CAS  PubMed  Google Scholar 

  9. Liebman HA, McGehee WG, Patch MJ, Feinstein DI. Severe depression of antithrombin III associated with disseminated intravascular coagulation in women with fatty liver of pregnancy. Ann Intern Med. 1983;98:330.

    Article  CAS  PubMed  Google Scholar 

  10. Fair DS, Marlar RA. Biosynthesis and secretion of factor VII, protein C, protein S, and the protein C inhibitor from a human hepatoma cell line. Blood. 1986;67:64.

    CAS  PubMed  Google Scholar 

  11. Mannucci PM, Vigano S. Deficiencies of protein C, an inhibitor of blood coagulation. Lancet. 1982;2:463.

    Article  CAS  PubMed  Google Scholar 

  12. Senzolo M, Cholongitas EC, Patch D, Burroughs AK. Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol. 2005;2:182.

    Article  PubMed  Google Scholar 

  13. Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280.

    Article  CAS  PubMed  Google Scholar 

  14. Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24:250.

    Article  PubMed  Google Scholar 

  15. Segev DL, Nguyen GC, Locke JE, Simpkins CE, Montgomery RA, Maley WR, et al. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl. 2007;13:1285.

    Article  PubMed  Google Scholar 

  16. Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol. 2010;52:355.

    Article  CAS  PubMed  Google Scholar 

  17. Rossetto V, Spiezia L, Senzolo M, Rodriguez-Castro KI, Maggiolo S, Simioni P. Whole blood rotation thromboelastometry (ROTEM(R)) profiles in subjects with non-neoplastic portal vein thrombosis. Thromb Res. 2013;132:e131.

    Article  CAS  PubMed  Google Scholar 

  18. Debernardi Venon W, Ponzo P, Sacco M, Mengozzi G, Raso S, Valpreda A, et al. Usefulness of thromboelastometry in predicting the risk of bleeding in cirrhotics who undergo invasive procedures. Eur J Gastroenterol Hepatol. 2015;27:1313.

    Article  PubMed  Google Scholar 

  19. Zanetto A, Senzolo M, Vitale A, Cillo U, Radu C, Sartorello F, et al. Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma. Dig Liver Dis. 2017;49:440.

    Article  PubMed  Google Scholar 

  20. Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005;54:691.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol. 2009;51:682.

    Article  PubMed  Google Scholar 

  22. Abdel-Razik A, Mousa N, Elhelaly R, Tawfik A. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system. Eur J Gastroenterol Hepatol. 2015;27:585.

    Article  PubMed  Google Scholar 

  23. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Sacco M, Martino R, et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy. 2002;34:535.

    Article  CAS  PubMed  Google Scholar 

  24. John BV, Konjeti R, Aggarwal A, Lopez R, Atreja A, Miller C, et al. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol. 2013;12:952.

    CAS  PubMed  Google Scholar 

  25. Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013;108:568.

    Article  PubMed  Google Scholar 

  26. Nery F, Chevret S, Condat B, de Raucourt E, Boudaoud L, Rautou PE, et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology. 2015;61:660.

    Article  CAS  PubMed  Google Scholar 

  27. Villa E, Camma C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. 2012;143:1253.

    Article  CAS  PubMed  Google Scholar 

  28. Rodriguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation. 2012;94:1145.

    Article  PubMed  Google Scholar 

  29. Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol. 2006;12:2115.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Senzolo M, Caldwell S. Portal vein thrombosis in cirrhosis: ignore, prevent, or treat? Gastroenterology. 2013;144:e19.

    Article  PubMed  Google Scholar 

  31. Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther. 2010;31:366.

    Article  CAS  PubMed  Google Scholar 

  32. Yerdel MA, Gunson B, Mirza D, Karayalcin K, Olliff S, Buckels J, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation. 2000;69:1873.

    Article  CAS  PubMed  Google Scholar 

  33. La Mura V, Tripodi A, Tosetti G, Cavallaro F, Chantarangkul V, Colombo M, et al. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis. Liver Int. 2016;36:1322.

    Article  PubMed  CAS  Google Scholar 

  34. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D’Andrea G, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology. 2000;31:345.

    Article  CAS  PubMed  Google Scholar 

  35. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736.

    Article  PubMed  Google Scholar 

  36. Mangia A, Villani MR, Cappucci G, Santoro R, Ricciardi R, Facciorusso D, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol. 2005;17:745.

    Article  CAS  PubMed  Google Scholar 

  37. European Association for the Study of the Liver. Electronic address eee. EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2016;64:179.

    Article  Google Scholar 

  38. Luca A, Caruso S, Milazzo M, Marrone G, Mamone G, Crino F, et al. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology. 2012;265:124.

    Article  PubMed  Google Scholar 

  39. Senzolo M, T MS, Rossetto V, Burra P, Cillo U, Boccagni P, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012;32:919.

    Article  CAS  PubMed  Google Scholar 

  40. D’Amico G, De Franchis R, Cooperative Study G. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599.

    Article  PubMed  Google Scholar 

  41. Senzolo M. Liver: PVT in cirrhosis, not always an innocent bystander. Nat Rev Gastroenterol Hepatol. 2015;12:11.

    Article  PubMed  Google Scholar 

  42. Olausson M, Norrby J, Mjornstedt L, Liden H, Friman S. Liver transplantation using cavoportal hemitransposition- a life-saving procedure in the presence of extensive portal vein thrombosis. Transplant Proc. 2001;33:1327.

    Article  CAS  PubMed  Google Scholar 

  43. Pinna AD, Nery J, Kato T, Levi D, Nishida S, Tzakis AG. Liver transplant with portocaval hemitransposition: experience at the University of Miami. Transplant Proc. 2001;33:1329.

    Article  CAS  PubMed  Google Scholar 

  44. Ravaioli M, Zanello M, Grazi GL, Ercolani G, Cescon M, Del Gaudio M, et al. Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg. 2011;253:378.

    Article  PubMed  Google Scholar 

  45. Ceulemans B, Aerts R, Monbaliu D, Coosemans W, Verslype C, Van Steenbergen W, et al. Liver transplantation using cavoportal transposition: an effective treatment in patients with complete splanchnic venous thrombosis. Transplant Proc. 2005;37:1112.

    Article  CAS  PubMed  Google Scholar 

  46. Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2010;44:448.

    CAS  PubMed  Google Scholar 

  47. Ageno W, Riva N, Schulman S, Beyer-Westendorf J, Bang SM, Senzolo M, et al. Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry. JAMA Intern Med. 2015;175:1474.

    Article  PubMed  Google Scholar 

  48. Chen H, Liu L, Qi X, He C, Wu F, Fan D, et al. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2016;28:82.

    Article  PubMed  CAS  Google Scholar 

  49. Cui SB, Shu RH, Yan SP, Wu H, Chen Y, Wang L, et al. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B. Eur J Gastroenterol Hepatol. 2015;27:914.

    Article  CAS  PubMed  Google Scholar 

  50. Delgado MG, Seijo S, Yepes I, Achecar L, Catalina MV, Garcia-Criado A, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol. 2012;10:776.

    Article  PubMed  Google Scholar 

  51. Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, et al. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013;58:1776.

    Article  CAS  PubMed  Google Scholar 

  52. Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto P, et al. Consensus conference on TIPS management: techniques, indications, contraindications. Dig Liver Dis. 2017;49:121.

    Article  PubMed  Google Scholar 

  53. Luca A, Miraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut. 2011;60:846.

    Article  PubMed  Google Scholar 

  54. Senzolo M, Burra P, Patch D, Burroughs AK. Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipe. J Hepatol. 2011;55:945.

    Article  PubMed  Google Scholar 

  55. Rossle M. TIPS: 25 years later. J Hepatol. 2013;59:1081.

    Article  PubMed  Google Scholar 

  56. Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology. 1998;28:1191.

    Article  CAS  PubMed  Google Scholar 

  57. Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, et al. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol. 1995;22:1.

    Article  CAS  PubMed  Google Scholar 

  58. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology. 2003;38:793.

    Article  PubMed  Google Scholar 

  59. Valla DC. Primary Budd-Chiari syndrome. J Hepatol. 2009;50:195.

    Article  PubMed  Google Scholar 

  60. Denninger MH, Beldjord K, Durand F, Denie C, Valla D, Guillin MC. Budd-Chiari syndrome and factor V Leiden mutation. Lancet. 1995;345:525.

    Article  CAS  PubMed  Google Scholar 

  61. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood. 2000;96:2364.

    CAS  PubMed  Google Scholar 

  62. Hirshberg B, Shouval D, Fibach E, Friedman G, Ben-Yehuda D. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. J Hepatol. 2000;32:574.

    Article  CAS  PubMed  Google Scholar 

  63. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434:1144.

    Article  CAS  PubMed  Google Scholar 

  64. Abhinav J, Pratik T, Akash S. Calreticulin mutations and their importance in Budd-Chiari syndrome. J Hepatol. 2017;67(5):1111–2.

    Article  CAS  Google Scholar 

  65. Plompen EP, Valk PJ, Chu I, Darwish Murad SD, Plessier A, Turon F, et al. Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis. Haematologica. 2015;100:e226.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  66. Turon F, Cervantes F, Colomer D, Baiges A, Hernandez-Gea V, Garcia-Pagan JC. Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis. J Hepatol. 2015;62:72.

    Article  CAS  PubMed  Google Scholar 

  67. Poisson J, Plessier A, Kiladjian JJ, Turon F, Cassinat B, Andreoli A, et al. Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: a prospective cohort study. J Hepatol. 2017;67:501.

    Article  CAS  PubMed  Google Scholar 

  68. Minnema MC, Janssen HL, Niermeijer P, de Man RA. Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability. J Hepatol. 2000;33:509.

    Article  CAS  PubMed  Google Scholar 

  69. Gupta S, Barter S, Phillips GW, Gibson RN, Hodgson HJ. Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome. Gut. 1987;28:242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 2009;151:167.

    Article  PubMed  Google Scholar 

  71. Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006;101:83.

    Article  PubMed  Google Scholar 

  72. Ohta M, Hashizume M, Tomikawa M, Ueno K, Tanoue K, Sugimachi K. Analysis of hepatic vein waveform by Doppler ultrasonography in 100 patients with portal hypertension. Am J Gastroenterol. 1994;89:170.

    CAS  PubMed  Google Scholar 

  73. Erden A, Erden I, Karayalcin S, Yurdaydin C. Budd-Chiari syndrome: evaluation with multiphase contrast-enhanced three-dimensional MR angiography. AJR Am J Roentgenol. 2002;179:1287.

    Article  PubMed  Google Scholar 

  74. Langlet P, Escolano S, Valla D, Coste-Zeitoun D, Denie C, Mallet A, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol. 2003;39:496.

    Article  PubMed  Google Scholar 

  75. Singh V, Sinha SK, Nain CK, Bambery P, Kaur U, Verma S, et al. Budd-Chiari syndrome: our experience of 71 patients. J Gastroenterol Hepatol. 2000;15:550.

    Article  CAS  PubMed  Google Scholar 

  76. Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol. 2001;35:338.

    Article  CAS  PubMed  Google Scholar 

  77. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38:364.

    Article  PubMed  Google Scholar 

  78. Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology. 1994;106:1042.

    Article  CAS  PubMed  Google Scholar 

  79. Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis. 2002;22:15.

    Article  PubMed  Google Scholar 

  80. Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999;30:84.

    Article  CAS  PubMed  Google Scholar 

  81. Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004;39:500.

    Article  PubMed  Google Scholar 

  82. Moucari R, Rautou PE, Cazals-Hatem D, Geara A, Bureau C, Consigny Y, et al. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut. 2008;57:828.

    Article  CAS  PubMed  Google Scholar 

  83. Shrestha SM, Okuda K, Uchida T, Maharjan KG, Shrestha S, Joshi BL, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol. 1996;11:170.

    Article  CAS  PubMed  Google Scholar 

  84. Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology. 2006;44:1308.

    Article  PubMed  Google Scholar 

  85. Seijo S, Plessier A, Hoekstra J, Dell’era A, Mandair D, Rifai K, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 2013;57:1962.

    Article  PubMed  Google Scholar 

  86. Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP. Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol. 2004;40:172.

    Article  CAS  PubMed  Google Scholar 

  87. Smalberg JH, Spaander MV, Jie KS, Pattynama PM, van Buuren HR, van den Berg B, et al. Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost. 2008;100:1084.

    Article  CAS  PubMed  Google Scholar 

  88. Frank JW, Kamath PS, Stanson AW. Budd-Chiari syndrome: early intervention with angioplasty and thrombolytic therapy. Mayo Clin Proc. 1994;69:877.

    Article  CAS  PubMed  Google Scholar 

  89. Raju GS, Felver M, Olin JW, Satti SD. Thrombolysis for acute Budd-Chiari syndrome: case report and literature review. Am J Gastroenterol. 1996;91:1262.

    CAS  PubMed  Google Scholar 

  90. Griffith JF, Mahmoud AE, Cooper S, Elias E, West RJ, Olliff SP. Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol. 1996;51:775.

    Article  CAS  PubMed  Google Scholar 

  91. Kuo GP, Brodsky RA, Kim HS. Catheter-directed thrombolysis and thrombectomy for the Budd-Chiari syndrome in paroxysmal nocturnal hemoglobinuria in three patients. J Vasc Interv Radiol. 2006;17:383.

    Article  PubMed  Google Scholar 

  92. Sang HF, Li XQ. Endovascular treatment of Budd-Chiari syndrome with hepatic vein obstruction in China. J Laparoendosc Adv Surg Tech A. 2014;24:846.

    Article  PubMed  Google Scholar 

  93. Slakey DP, Klein AS, Venbrux AC, Cameron JL. Budd-Chiari syndrome: current management options. Ann Surg. 2001;233:522.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Zhang Q, Xu H, Zu M, Gu Y, Wei N, Wang W, et al. Catheter-directed thrombolytic therapy combined with angioplasty for hepatic vein obstruction in Budd-Chiari syndrome complicated by thrombosis. Exp Ther Med. 2013;6:1015.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut. 2006;55:878.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Zhang CQ, Fu LN, Xu L, Zhang GQ, Jia T, Liu JY, et al. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol. 2003;9:2587.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg. 2000;232:340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology. 1995;21:1337.

    Article  CAS  PubMed  Google Scholar 

  99. Attwell A, Ludkowski M, Nash R, Kugelmas M. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment Pharmacol Ther. 2004;20:867.

    Article  CAS  PubMed  Google Scholar 

  100. Fan X, Liu K, Che Y, Wang S, Wu X, Cao J, et al. Good clinical outcomes in Budd-Chiari syndrome with hepatic vein occlusion. Dig Dis Sci. 2016;61:3054.

    Article  CAS  PubMed  Google Scholar 

  101. Garcia-Pagan JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology. 2008;135:808.

    Article  PubMed  Google Scholar 

  102. Hayek G, Ronot M, Plessier A, Sibert A, Abdel-Rehim M, Zappa M, et al. Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-Chiari syndrome. Radiology. 2017;283:280.

    Article  PubMed  Google Scholar 

  103. Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology. 2004;40:1197.

    Article  PubMed  Google Scholar 

  104. Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, et al. TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. J Hepatol. 2003;38:751.

    Article  PubMed  Google Scholar 

  105. Mo A, Testro A, French J, Robertson M, Angus P, Grigg A. Early radiological intervention and haematology screening is associated with excellent outcomes in Budd Chiari syndrome. Intern Med J. 2017;47:1361.

    Article  CAS  PubMed  Google Scholar 

  106. Perello A, Garcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002;35:132.

    Article  PubMed  Google Scholar 

  107. Qi X, Guo W, He C, Zhang W, Wu F, Yin Z, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int. 2014;34:1164.

    Article  PubMed  Google Scholar 

  108. Rosenqvist K, Sheikhi R, Eriksson LG, Rajani R, Rorsman F, Sangfelt P, et al. Endovascular treatment of symptomatic Budd-Chiari syndrome – in favour of early transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol. 2016;28:656.

    Article  CAS  PubMed  Google Scholar 

  109. Rossle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery. 2004;135:394.

    Article  PubMed  Google Scholar 

  110. Tripathi D, Macnicholas R, Kothari C, Sunderraj L, Al-Hilou H, Rangarajan B, et al. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther. 2014;39:864.

    Article  CAS  PubMed  Google Scholar 

  111. Rossle M, Richter GM, Noldge G, Palmaz JC, Wenz W, Gerok W. New non-operative treatment for variceal haemorrhage. Lancet. 1989;2:153.

    Article  CAS  PubMed  Google Scholar 

  112. Keller FS, Farsad K, Rosch J. The transjugular intrahepatic portosystemic shunt: technique and instruments. Tech Vasc Interv Radiol. 2016;19:2.

    Article  PubMed  Google Scholar 

  113. Campbell DA Jr, Rolles K, Jamieson N, O’Grady J, Wight D, Williams R, et al. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet. 1988;166:511.

    PubMed  Google Scholar 

  114. Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transpl. 2005;19:501.

    Article  Google Scholar 

  115. Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver transplantation for the Budd-Chiari syndrome. Ann Surg. 1990;211:43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Jamieson NV, Williams R, Calne RY. Liver transplantation for Budd-Chiari syndrome, 1976-1990. Ann Chir. 1991;45:362.

    CAS  PubMed  Google Scholar 

  117. Oldakowska-Jedynak U, Ziarkiewicz M, Ziarkiewicz-Wroblewska B, Dwilewicz-Trojaczek J, Gornicka B, Nyckowski P, et al. Myeloproliferative neoplasms and recurrent thrombotic events in patients undergoing liver transplantation for Budd-Chiari syndrome: a single-center experience. Ann Transplant. 2014;19:591.

    Article  CAS  PubMed  Google Scholar 

  118. Raza SM, Zainab S, Shamsaeefar AR, Nikeghbalian S, Malek Hosseini SA. Experience of liver transplant in patients diagnosed with Budd-Chiari syndrome. Exp Clin Transplant. 2018;16(2):177–81.

    Google Scholar 

  119. Sakai Y, Wall WJ. Liver transplantation for Budd-Chiari syndrome: a retrospective study. Surg Today. 1994;24:49.

    Article  CAS  PubMed  Google Scholar 

  120. Shaked A, Goldstein RM, Klintmalm GB, Drazan K, Husberg B, Busuttil RW. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet. 1992;174:453.

    CAS  PubMed  Google Scholar 

  121. Srinivasan P, Rela M, Prachalias A, Muiesan P, Portmann B, Mufti GJ, et al. Liver transplantation for Budd-Chiari syndrome. Transplantation. 2002;73:973.

    Article  PubMed  Google Scholar 

  122. Ulrich F, Pratschke J, Neumann U, Pascher A, Puhl G, Fellmer P, et al. Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome. Liver Transpl. 2008;14:144.

    Article  PubMed  Google Scholar 

  123. Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O’Grady J, et al. Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres. J Hepatol. 2006;44:520.

    Article  PubMed  Google Scholar 

  124. Klein AS, Molmenti EP. Surgical treatment of Budd-Chiari syndrome. Liver Transpl. 2003;9:891.

    Article  PubMed  Google Scholar 

  125. Melear JM, Goldstein RM, Levy MF, Molmenti EP, Cooper B, Netto GJ, et al. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation. 2002;74:1090.

    Article  CAS  PubMed  Google Scholar 

  126. Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci. 2008;53:3012.

    Article  PubMed  Google Scholar 

  127. Northup PG, McMahon MM, Ruhl AP, Altschuler SE, Volk-Bednarz A, Caldwell SH, et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol. 2006;101:1524.

    Article  PubMed  Google Scholar 

  128. Dabbagh O, Oza A, Prakash S, Sunna R, Saettele TM. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest. 2010;137:1145.

    Article  PubMed  Google Scholar 

  129. Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med. 2007;167:935.

    Article  PubMed  Google Scholar 

  130. Al-Dorzi HM, Tamim HM, Aldawood AS, Arabi YM. Venous thromboembolism in critically ill cirrhotic patients: practices of prophylaxis and incidence. Thrombosis. 2013;2013:807526.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  131. Aldawood A, Arabi Y, Aljumah A, Alsaadi A, Rishu A, Aldorzi H, et al. The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J. 2011;9:1.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Ali M, Ananthakrishnan AN, McGinley EL, Saeian K. Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci. 2011;56:2152.

    Article  PubMed  Google Scholar 

  133. Garcia-Fuster MJ, Abdilla N, Fabia MJ, Fernandez C, Oliver V, Forner MJ. Venous thromboembolism and liver cirrhosisRev Esp Enferm Dig. 2008;100:259.

    Article  CAS  PubMed  Google Scholar 

  134. Girleanu I, Trifan A, Cojocariu C, Singeap AM, Sfarti C, Stanciu C. The risk of thrombotic events in patients with liver cirrhosis. Rev Med Chir Soc Med Nat Iasi. 2012;116:991.

    PubMed  Google Scholar 

  135. Lesmana CR, Inggriani S, Cahyadinata L, Lesmana LA. Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int. 2010;4:433.

    Article  PubMed  PubMed Central  Google Scholar 

  136. Shah NL, Northup PG, Caldwell SH. A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients. Ann Hepatol. 2012;11:686.

    PubMed  Google Scholar 

  137. Bogari H, Patanwala AE, Cosgrove R, Katz M. Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease. Thromb Res. 2014;134:1220.

    Article  CAS  PubMed  Google Scholar 

  138. Excellence NIfHaC. Venous thromboembolism: reducing the risk for patients in hospital (update 2015). http://www.nice.org.uk/CG092. 2015.

  139. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387.

    Article  PubMed  Google Scholar 

  140. Barclay SM, Jeffres MN, Nguyen K, Nguyen T. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease. Pharmacotherapy. 2013;33:375.

    Article  PubMed  Google Scholar 

  141. Pincus KJ, Tata AL, Watson K. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis. Ann Pharmacother. 2012;46:873.

    Article  PubMed  Google Scholar 

  142. Bechmann LP, Wichert M, Kroger K, Hilgard P. Dosing and monitoring of low-molecular-weight heparin in cirrhotic patients. Liver Int. 2011;31:1064.

    Article  PubMed  Google Scholar 

  143. Lisman T, Porte RJ. Towards a rational use of low-molecular-weight heparin in patients with cirrhosis. Liver Int. 2011;31:1063.

    Article  PubMed  Google Scholar 

  144. Lehman CM, Rettmann JA, Wilson LW, Markewitz BA. Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin. Am J Clin Pathol. 2006;126:416.

    Article  CAS  PubMed  Google Scholar 

  145. Senzolo M, Rodriguez-Castro KI, Rossetto V, Radu C, Gavasso S, Carraro P, et al. Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis. J Thromb Haemost. 2012;10:1823.

    Article  CAS  PubMed  Google Scholar 

  146. Tripodi A, Primignani M, Braham S, Chantarangkul V, Clerici M, Moia M, et al. Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonists. Dig Liver Dis. 2016;48:1208.

    Article  PubMed  Google Scholar 

  147. Brigden ML, Kay C, Le A, Graydon C, McLeod B. Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population. Am J Hematol. 1998;59:22.

    Article  CAS  PubMed  Google Scholar 

  148. Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Meijers JC, et al. Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis. PLoS One. 2014;9:e88390.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  149. Potze W, Adelmeijer J, Lisman T. Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis. Hepatology. 2015;61:1435.

    Article  CAS  PubMed  Google Scholar 

  150. Intagliata NM, Henry ZH, Maitland H, Shah NL, Argo CK, Northup PG, et al. Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation. Dig Dis Sci. 2016;61:1721.

    Article  CAS  PubMed  Google Scholar 

  151. De Gottardi A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, et al. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis. Liver Int. 2017;37:694.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Multivisceral Transplant Unit, Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy

    Alberto Zanetto & Marco Senzolo

Authors
  1. Alberto Zanetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Senzolo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Anesthesiology and Perioperative Medicine, Penn State Hershey Medical Center, Hershey, PA, USA

    Dmitri Bezinover

  2. General, Visceral and Transplant Surgery, University of Duisburg-Essen, Essen, Germany

    Fuat Saner

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zanetto, A., Senzolo, M. (2019). Management of Thrombosis in the Liver Transplant Candidate. In: Bezinover, D., Saner, F. (eds) Critical Care for Potential Liver Transplant Candidates. Springer, Cham. https://doi.org/10.1007/978-3-319-92934-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92934-7_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92933-0

  • Online ISBN: 978-3-319-92934-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation